05.11.2012 Views

Hypoglycemia in the newborn period - New Born Baby

Hypoglycemia in the newborn period - New Born Baby

Hypoglycemia in the newborn period - New Born Baby

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

AIIMS- NICU protocols updated 2007<br />

mg/dl after 24 hours of parentral <strong>the</strong>rapy, <strong>the</strong> <strong>in</strong>fusion can be tapered off at <strong>the</strong> rate of 2<br />

mg/kg/m<strong>in</strong> every 6 hours, with glucose monitor<strong>in</strong>g. Taper<strong>in</strong>g has to be accompanied by<br />

concomitant <strong>in</strong>crease <strong>in</strong> oral feeds. Once a rate of 4 mg/kg/m<strong>in</strong> of glucose <strong>in</strong>fusion is reached<br />

and oral <strong>in</strong>take is adequate and <strong>the</strong> blood sugar values are consistently > 50 mg/dL <strong>the</strong> <strong>in</strong>fusion<br />

can be stopped without fur<strong>the</strong>r taper<strong>in</strong>g. Ensure cont<strong>in</strong>uous glucose <strong>in</strong>fusion without any<br />

<strong>in</strong>terruption preferably us<strong>in</strong>g <strong>in</strong>fusion pump.<br />

Do not stop an IV <strong>in</strong>fusion of glucose abruptly; severe rebound hypoglycemia may occur. Avoid<br />

us<strong>in</strong>g > 12.5% dextrose <strong>in</strong>fusion through a peripheral ve<strong>in</strong> due to <strong>the</strong> risk of thrombophlebitis<br />

Recurrent / resistant hypoglycemia<br />

This condition should be considered when <strong>the</strong>re is a failure to ma<strong>in</strong>ta<strong>in</strong> normal blood sugar<br />

levels despite a glucose <strong>in</strong>fusion of 12 mg/kg/m<strong>in</strong> or when stabilization is not achieved by 7<br />

days of life. High levels of glucose <strong>in</strong>fusion may be needed <strong>in</strong> <strong>the</strong> <strong>in</strong>fants to achieve euglycemia.<br />

Table no 4 : Important causes of resistant hypoglycemia and <strong>in</strong>vestigations<br />

Important causes of resistant hypoglycemia Investigations to be considered<br />

Congenital hypopitutarism<br />

Serum <strong>in</strong>sul<strong>in</strong> levels<br />

Adrenal <strong>in</strong>sufficiency<br />

Hyper<strong>in</strong>sulenemic states<br />

Galactosemia<br />

Glycogen storage disorders<br />

Maple syrup ur<strong>in</strong>e disease<br />

Mitochondrial disorders<br />

Serum cortisol levels<br />

Growth hormone levels<br />

Blood ammonia<br />

Blood lactate levels<br />

Ur<strong>in</strong>e ketones and reduc<strong>in</strong>g substances<br />

Ur<strong>in</strong>e and sugar am<strong>in</strong>oacidogram<br />

Besides <strong>in</strong>creas<strong>in</strong>g <strong>the</strong> rate of glucose <strong>in</strong>fusion, drugs may also be tried <strong>in</strong> <strong>the</strong> treatment of<br />

resistant hypoglycemia. Before adm<strong>in</strong>istration of <strong>the</strong> drugs , take <strong>the</strong> samples to <strong>in</strong>vestigate <strong>the</strong><br />

cause (Table no 3) . Drugs that are used <strong>in</strong>clude <strong>the</strong> follow<strong>in</strong>g:<br />

Downloaded from www.<strong>newborn</strong>whocc.org<br />

8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!